Arya M. Sharma

Active 1989–2025

136
Papers
32,274
Citations
91
h-index
132
i10-index

Citations

Citations per year for Arya M. Sharma1990: 1 citations1991: 3 citations1992: 1 citations1993: 5 citations1994: 3 citations1995: 2 citations1996: 7 citations1997: 26 citations1998: 39 citations1999: 62 citations2000: 82 citations2001: 78 citations2002: 87 citations2003: 147 citations2004: 202 citations2005: 203 citations2006: 245 citations2007: 290 citations2008: 302 citations2009: 281 citations2010: 282 citations2011: 361 citations2012: 316 citations2013: 344 citations2014: 306 citations2015: 256 citations2016: 239 citations2017: 217 citations2018: 195 citations2019: 588 citations2020: 687 citations2021: 644 citations2022: 495 citations2023: 393 citations2024: 635 citations2025: 319 citations2026: 14 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,606 citing papers, 22.6% of this breakdownCanada: 811 citing papers, 7.1% of this breakdownUnited Kingdom: 810 citing papers, 7% of this breakdownItaly: 649 citing papers, 5.7% of this breakdownGermany: 590 citing papers, 5.1% of this breakdownChina: 517 citing papers, 4.5% of this breakdownAustralia: 403 citing papers, 3.5% of this breakdownSpain: 338 citing papers, 2.9% of this breakdownNetherlands: 334 citing papers, 2.9% of this breakdownFrance: 312 citing papers, 2.7% of this breakdownSweden: 255 citing papers, 2.2% of this breakdownJapan: 244 citing papers, 2.1% of this breakdown
0%22.6%Other 31.7%

Fields

  • Medicine75.9%
  • Biochemistry, Genetics and Molecular Biology9.2%
  • Health Professions5%
  • Nursing3.3%
  • Neuroscience2.3%
  • Psychology1.4%
  • Other2.9%

Topics

  • Bariatric Surgery and Outcomes5.4%
  • Adipokines, Inflammation, and Metabolic Diseases4.9%
  • Cardiovascular Disease and Adiposity4.9%
  • Adipose Tissue and Metabolism3.9%
  • Diet and metabolism studies3.2%
  • Cardiovascular Function and Risk Factors2.9%
  • Other74.8%

Coauthors

All papers

Open in search
  1. Obesity in adults: a clinical practice guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy Kemp, Sara Kirk, Jennifer L. Kuk, Marie‐France Langlois, Scott A. Lear, Ashley McInnes, David Macklin, Leen Naji, Priya Manjoo, Marie‐Philippe Morin, Kara Nerenberg, Ian Patton, Sue D. Pedersen, Leticia Pereira, Helena Piccinini‐Vallis, Megha Poddar, Paul Poirier, Denis Prud’homme, Ximena Ramos Salas, Christian F. Rueda‐Clausen, Shelly Russell‐Mayhew, Judy Shiau, Diana Sherifali, John L. Sievenpiper, Sanjeev Sockalingam, Valerie H. Taylor, Ellen L. Toth, Laurie Twells, Richard Tytus, Shahebina Walji, Leah Walker, Sonja Wicklum - Canadian Medical Association Journal 2020 cited by 1,444

  2. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study

    Authors: , , , , , , , , , , , , , , - The Lancet 2005 cited by 2,897

  3. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart

    Authors: , , - Nature Clinical Practice Cardiovascular Medicine 2005 cited by 1,010

  4. A proposed clinical staging system for obesity

    Authors: , - International Journal of Obesity 2009 cited by 659

  5. IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management—an International Delphi Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sílvia Leite Faria, Guilherme Macedo, Alexander D. Miras, Violeta Moizé, François Pattou, Luis Poggi, Jaime Ponce, Almino Ramos, Francesco Rubino, Andrés Sánchez-Pernaute, David B. Sarwer, Arya M. Sharma, Christine Stier, Christopher Thompson, Josép Vidal, Tarissa Beatrice Zanata Petry - Obesity Surgery 2023 cited by 189

  6. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

    Authors: , , , , , , , , , , - New England Journal of Medicine 2010 cited by 934

  7. Weight Recidivism Post-Bariatric Surgery: A Systematic Review

    Authors: , , , , , - Obesity Surgery 2013 cited by 570

  8. Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery

    Authors: , , , - Obesity Surgery 2018 cited by 96

  9. Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling

    Authors: , , , , , , , , , , , , , - Cardiovascular Research 2014 cited by 219

  10. Weight bias reduction in health professionals: a systematic review

    Authors: , , , , , , , , , - Clinical Obesity 2016 cited by 239

  11. A comprehensive diagnostic approach to detect underlying causes of obesity in adults

    Authors: , , , , , , , - Obesity Reviews 2019 cited by 127

  12. Prevalence of Sarcopenic Obesity in Adults with Class II/III Obesity Using Different Diagnostic Criteria

    Authors: , , , , , - Journal of Nutrition and Metabolism 2017 cited by 288

  13. Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the STEP 1–4 trials

    Authors: , , , , , , , , - Diabetes Obesity and Metabolism 2024 cited by 39

  14. Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy

    Authors: , , , , , - BMJ Open Diabetes Research & Care 2017 cited by 169

  15. Activation of the Peripheral Endocannabinoid System in Human Obesity

    Authors: , , , , , , , , , , - Diabetes 2005 cited by 690

  16. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity

    Authors: , , , - Canadian Medical Association Journal 2011 cited by 380

  17. The Obesity Paradox in the Elderly: Potential Mechanisms and Clinical Implications

    Authors: , , , - Clinics in Geriatric Medicine 2009 cited by 323

  18. Perceptions of barriers to effective obesity management in Canada: Results from the ACTION study

    Authors: , , , , , , , , , , , , , - Clinical Obesity 2019 cited by 88

  19. Lowering Body Weight in Obese Mice With Diastolic Heart Failure Improves Cardiac Insulin Sensitivity and Function: Implications for the Obesity Paradox

    Authors: , , , , , , , , , - Diabetes 2014 cited by 77

  20. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]

    Authors: , , , , , - Canadian Medical Association Journal 2007 cited by 1,168

  21. Hypothesis: β-Adrenergic Receptor Blockers and Weight Gain

    Authors: , , , , - Hypertension 2001 cited by 335

  22. Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)

    Authors: , , , , , , , , , , , , , , , , , , , , , - Obesity Surgery 2016 cited by 296

  23. Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity

    Authors: , , , , , , , , , , , - Diabetes Obesity and Metabolism 2019 cited by 54

  24. Weight Loss and the Renin-Angiotensin-Aldosterone System

    Authors: , , , , , , , - Hypertension 2005 cited by 623